Guanine nucleotide exchange factor VAV3 is a protein that in humans is encoded by the VAV3gene.
This gene is a member of the VAV gene family. The VAV proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases that activate pathways leading to actin cytoskeletal rearrangements and transcriptional alterations. This gene product acts as a GEF preferentially for RhoG, RhoA, and to a lesser extent, RAC1, and it associates maximally with the nucleotide-free states of these GTPases. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Trenkle T, McClelland M, Adlkofer K, Welsh J (2000). "Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors". Gene245 (1): 139–149. doi:10.1016/S0378-1119(00)00026-3. PMID10713454.
Yabana N, Shibuya M (2002). "Adaptor protein APS binds the NH2-terminal autoinhibitory domain of guanine nucleotide exchange factor Vav3 and augments its activity". Oncogene21 (50): 7720–7729. doi:10.1038/sj.onc.1205927. PMID12400014.
Ota T, Suzuki Y, Nishikawa T et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet.36 (1): 40–45. doi:10.1038/ng1285. PMID14702039.
Pearce AC, Senis YA, Billadeau DD et al. (2005). "Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen". J. Biol. Chem.279 (52): 53955–53962. doi:10.1074/jbc.M410355200. PMID15456756.
Charvet C, Canonigo AJ, Billadeau DD, Altman A (2005). "Membrane localization and function of Vav3 in T cells depend on its association with the adapter SLP-76". J. Biol. Chem.280 (15): 15289–15299. doi:10.1074/jbc.M500275200. PMID15708849.
Lyons LS, Burnstein KL (2006). "Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity". Mol. Endocrinol.20 (5): 1061–1072. doi:10.1210/me.2005-0346. PMID16384856.
Dong Z, Liu Y, Lu S et al. (2006). "Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer". Mol. Endocrinol.20 (10): 2315–2325. doi:10.1210/me.2006-0048. PMID16762975.